Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J OSBORNE

Showing results (491-500 of 664) with videos related to

Pageof 67
Sort By:
Water Research|February 23, 2020
Implementation of quantitative microbial risk assessment (QMRA) for public drinking water supplies: Systematic reviewChristopher E L Owens, Mark L Angles, Peter T Cox, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 19, 2016
The Weather and Ménière's Disease: A Longitudinal Analysis in the UKWiebke Schmidt, Christophe Sarran, Natalie Ronan, et al.
Journal of Bacteriology|July 3, 2003
The solution structure of YbcJ from Escherichia coli reveals a recently discovered alphaL motif involved in RNA bindingLaurent Volpon, Carine Lievre, Michael J Osborne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
Toxicology Research|March 7, 2024
The <i>new normal</i> chemical landscape: the future of risk assessment toward optimum consumer safetyOlivia J Osborne, Alan Boobis, Phil Botham, et al.
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2002
Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's diseaseTracey K Murray, Marcus J Messenger, Mark A Ward, et al.
American Journal of Physiology. Cell Physiology|December 1, 2006
Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1John D Lueck, Codrin Lungu, Ami Mankodi, et al.
The Science of the Total Environment|May 9, 2017
Mapping allergenic pollen vegetation in UK to study environmental exposure and human healthRachel N McInnes, Deborah Hemming, Peter Burgess, et al.
Pageof 67

Showing results (491-500 of 664) with videos related to

Sort By:
Pageof 67
Water Research|February 23, 2020
Implementation of quantitative microbial risk assessment (QMRA) for public drinking water supplies: Systematic reviewChristopher E L Owens, Mark L Angles, Peter T Cox, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 19, 2016
The Weather and Ménière's Disease: A Longitudinal Analysis in the UKWiebke Schmidt, Christophe Sarran, Natalie Ronan, et al.
Journal of Bacteriology|July 3, 2003
The solution structure of YbcJ from Escherichia coli reveals a recently discovered alphaL motif involved in RNA bindingLaurent Volpon, Carine Lievre, Michael J Osborne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
Toxicology Research|March 7, 2024
The <i>new normal</i> chemical landscape: the future of risk assessment toward optimum consumer safetyOlivia J Osborne, Alan Boobis, Phil Botham, et al.
British Journal of Cancer|January 1, 1988
Tamoxifen in refractory ovarian cancer: the use of a loading dose scheduleR J Osborne, S T Malik, M L Slevin, et al.
Pharmacology, Biochemistry, and Behavior|July 16, 2002
Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's diseaseTracey K Murray, Marcus J Messenger, Mark A Ward, et al.
American Journal of Physiology. Cell Physiology|December 1, 2006
Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1John D Lueck, Codrin Lungu, Ami Mankodi, et al.
The Science of the Total Environment|May 9, 2017
Mapping allergenic pollen vegetation in UK to study environmental exposure and human healthRachel N McInnes, Deborah Hemming, Peter Burgess, et al.
Pageof 67